drugset
drugset / Trial / NCT04585841

The Effect of Cannabidiol on Lean Body Mass in Patients Receiving Chemotherapy

NCT04585841 ↗

Phase 1 Completed 32 enrolled University of Copenhagen Zealand University Hospital · collab
Non-randomizedParallel-groupOpen-labelSupportive care

Summary

An intervention study on the effect of cannabidiol on lean body mass in cancer patients receiving chemotherapy, at the department of Clinical Oncology at Zealand University Hospital, Roskilde, Denmark. Fat free mass will be measured by bioimpedance spectroscopy. As secondary outcomes protein and energy intake, nausea, taste alterations and life quality will be assessed by oral interviews and questionnaires.

Timeline

Start
2020-12-01
Primary completion
2021-08-30
Completion
2022-11-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Cannabidiol Other / unclassified 300 mg —

Indications

cancer